SARS-COV-2 VIRAEMIA

This adverse event was reported 58 times

These drugs are most commonly taken by patients reporting SARS-COV-2 VIRAEMIA:

# Drug Count
0 TACROLIMUS 33
1 TACROLIMUS EXTENDED-RELEASE CAPSULES 33
2 TACROLIMUS OINTMENT 0.1% 33
3 METHYLPREDNISOLONE 15
4 MYCOPHENOLATE MOFETIL 15
5 RITUXIMAB 15
6 PREDNISONE 14
7 DEXAMETHASONE 13
8 DEXAMETHASONE 1.5 MG 13
9 REMDESIVIR 12
See all common drugs associated with SARS-COV-2 VIRAEMIA

SARS-COV-2 VIRAEMIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REMDESIVIR 12 0.0009
1 BARICITINIB 1 0.0003
2 TACROLIMUS OINTMENT 0.1% 33 0.0003
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 33 0.0003
4 FOSCARNET SODIUM 1 0.0002
5 TACROLIMUS 33 0.0002
6 RITONAVIR 100 MG 3 0.0002
7 0XYGEN 7 0.0001
8 OXYGEN 7 0.0001
9 BENDAMUSTINE HCL 2 0.0001
See all drugs enriched for association with SARS-COV-2 VIRAEMIA